Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays

Internal Medicine Journal

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2vSdqEZ
via IFTTT